Astrotech Corporation (NASDAQ:ASTC – Get Free Report) saw a large decline in short interest in December. As of December 31st, there was short interest totaling 40,960 shares, a decline of 65.5% from the December 15th total of 118,829 shares. Based on an average daily trading volume, of 34,610 shares, the days-to-cover ratio is currently 1.2 days. Currently, 2.8% of the shares of the stock are short sold. Currently, 2.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 34,610 shares, the days-to-cover ratio is currently 1.2 days.
Astrotech Trading Up 3.7%
Shares of Astrotech stock opened at $3.61 on Wednesday. Astrotech has a 52 week low of $2.46 and a 52 week high of $8.01. The stock has a market cap of $6.35 million, a PE ratio of -0.43 and a beta of 0.34. The company’s 50-day moving average price is $3.50 and its two-hundred day moving average price is $4.49.
Astrotech (NASDAQ:ASTC – Get Free Report) last announced its quarterly earnings data on Thursday, November 13th. The aerospace company reported ($2.07) earnings per share (EPS) for the quarter. Astrotech had a negative return on equity of 59.71% and a negative net margin of 1,069.89%.The business had revenue of $0.30 million during the quarter.
Institutional Investors Weigh In On Astrotech
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Astrotech in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
View Our Latest Research Report on Astrotech
Astrotech Company Profile
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
See Also
- Five stocks we like better than Astrotech
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Ominous day” coming to stocks…
- Punch these codes into your ordinary brokerage account
- The Crash Has Already Started (Most Just Don’t See It Yet)
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
